Value through InnovationOctober 29 2014

Value Through Innovation is Our Vision

Boehringer Ingelheim, founded in 1885 by Albert Boehringer in Ingelheim, Germany, began with just 28 people employed to manufacture tartaric acid salts. Now, more than 125 years later, we are a global enterprise, employing more than 44,000 people in 50 countries. Our focus is primarily in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology.

Our Company Objectives

The objectives and beliefs of Boehringer Ingelheim can be summed up in a single phrase: Value through Innovation. This vision has helped us build on our strengths and make the most of our distinctive character for more than 125 years. Value through Innovation is what drives us to continuously search for new and innovative ways to improve the lives that we touch - whether that be lives of patients and their families, our employees or our community.

Learn more about our company awards and recognition, our locations and businesses or read through our most recent annual report.

More About Our Company

  • Company Awards & Recognition

    We are proud to be recognized for our company-wide efforts to improve the lives of patients and families, employees and for our work in the community.

  • Annual Report

    In the 2013 Annual Report, Boehringer Ingelheim posted net sales of $18.7 billion (USD) while spending almost 20% of its prescription medicine net sales on research and development.

  • Our Locations

    Boehringer Ingelheim has U.S. operations in Ridgefield, Connecticut, Cleveland and Columbus, Ohio, St. Joseph, Missouri, Fremont, California and Petersburg, Virginia.


"Our success depends on a diverse and talented workforce"

Paul Fonteyne

Paul Fonteyne - President and CEO, Boehringer Ingelheim USA (Country Managing Director)

Community Health Initiatives

Making More Health